research Novel Nanoparticulate Systems for Idiopathic Pulmonary Fibrosis: A Review 1 citations, November 2020 in “Asian Journal of Pharmaceutical and Clinical Research” Nanoparticles may improve treatment for lung disease by targeting cells better and reducing side effects.